TrialAdvances in therapy2023
A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes.
Ping Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it
TrialAdvances in therapy2023
Ping Feng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.